Across TCGA pan-cancer cohorts, MTCO1P39 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTCO1P39’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MTCO1P39 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTCO1P39 is over-expressed in tumor.

KIRP, KIRC, and LIHC are the cancer types where MTCO1P39 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCO1P39 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.043	.009	2	view →
KIRC	All	All	+0.033	.017	2	view →
LIHC	Male	All	+0.137	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MTCO1P39 RNA expression & survival · all MTCO1P39 data types